Your browser doesn't support javascript.
loading
Chinese Herbal Medicine Combined with Entecavir for HBeAg Positive Chronic Hepatitis B: Study Protocol for a Multi-Center, Double-Blind Randomized-Controlled Trial.
Ye, Yong-An; Li, Xiao-Ke; Zhou, Da-Qiao; Chi, Xiao-Ling; Li, Qin; Wang, Li; Lu, Bing-Jiu; Mao, De-Wen; Wu, Qi-Kai; Wang, Xian-Bo; Zhang, Ming-Xiang; Xue, Jing-Dong; Li, Yong; Lu, Wei; Guo, Jian-Chun; Jiang, Feng; Zhang, Xin-Wei; Du, Hong-Bo; Yang, Xian-Zhao; Guo, Hui; Gan, Da-Nan; Li, Zhi-Guo.
Afiliação
  • Ye YA; Institute of Liver Diseases, Beijing University of Chinese Medicine, Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine, Beijing, 100700, China. yeyongan@vip.163.com.
  • Li XK; Institute of Liver Diseases, Beijing University of Chinese Medicine, Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine, Beijing, 100700, China.
  • Zhou DQ; Department of Hepatology, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong Province, 518033, China.
  • Chi XL; Department of Hepatology, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou, 510006, China.
  • Li Q; Department of Hepatology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, China.
  • Wang L; Department of Hepatology, Public Health Clinical Center of Chengdu, Chengdu, 610066, China.
  • Lu BJ; Department of Hepatology, Liaoning Hospital of Traditional Chinese Medicine, Shenyang, 110032, China.
  • Mao DW; Department of Hepatology, the First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, 530023, China.
  • Wu QK; Department of Hepatology, the Third People's Hospital of Shenzhen, Shenzhen, Guangdong Province, 518112, China.
  • Wang XB; Department of Hepatology, Beijing Ditan Hospital, Beijing, 100015, China.
  • Zhang MX; Department of Hepatology, the Sixth People's Hospital of Shenyang, Shenyang, 110006, China.
  • Xue JD; Department of Hepatology, Shaanxi Hospital of Traditional Chinese Medicine, Xi'an, 710003, China.
  • Li Y; Department of Hepatology, Shandong Hospital of Traditional Chinese Medicine, Jinan, 250011, China.
  • Lu W; Department of Hepatology, the Second People's Hospital of Tianjin, Tianjin, 300000, China.
  • Guo JC; Department of Hepatology, Xixi Hospital of Hangzhou, Hangzhou, 310023, China.
  • Jiang F; Institute of Liver Diseases, Beijing University of Chinese Medicine, Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine, Beijing, 100700, China.
  • Zhang XW; Department of Hepatology, 302 Military Hospital of China, Beijing, 100039, China.
  • Du HB; Institute of Liver Diseases, Beijing University of Chinese Medicine, Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine, Beijing, 100700, China.
  • Yang XZ; Institute of Liver Diseases, Beijing University of Chinese Medicine, Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine, Beijing, 100700, China.
  • Guo H; Department of Hepatology, the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300000, China.
  • Gan DN; Institute of Liver Diseases, Beijing University of Chinese Medicine, Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine, Beijing, 100700, China.
  • Li ZG; Institute of Liver Diseases, Beijing University of Chinese Medicine, Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine, Beijing, 100700, China.
Chin J Integr Med ; 24(9): 653-660, 2018 Sep.
Article em En | MEDLINE | ID: mdl-30209792
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Medicamentos de Ervas Chinesas / Ensaios Clínicos Controlados Aleatórios como Assunto / Hepatite B Crônica / Guanina / Antígenos E da Hepatite B Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Chin J Integr Med Assunto da revista: TERAPIAS COMPLEMENTARES Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Medicamentos de Ervas Chinesas / Ensaios Clínicos Controlados Aleatórios como Assunto / Hepatite B Crônica / Guanina / Antígenos E da Hepatite B Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Chin J Integr Med Assunto da revista: TERAPIAS COMPLEMENTARES Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China